Luca Di Gianfrancesco, Alessandro Crestani, A. Amodeo, Paolo Corsi, Davide De Marchi, E. Miglioranza, G. Lista, Ferdinando Daniele Vitelli, Francesca Simonetti, G. Busetto, U. Falagario, Martina Maggi, Filippo Marino, Giannicola Genovese, R. Falabella, Angelo Porreca
{"title":"肾脏手术后局部复发的光与影:何时、为何以及如何处理","authors":"Luca Di Gianfrancesco, Alessandro Crestani, A. Amodeo, Paolo Corsi, Davide De Marchi, E. Miglioranza, G. Lista, Ferdinando Daniele Vitelli, Francesca Simonetti, G. Busetto, U. Falagario, Martina Maggi, Filippo Marino, Giannicola Genovese, R. Falabella, Angelo Porreca","doi":"10.3389/fruro.2024.1419418","DOIUrl":null,"url":null,"abstract":"This review aims to analyze the existing literature on local recurrence (LR) in patients undergoing partial nephrectomy (PN) for renal cell carcinoma, identifying relative risk factors, and exploring optimal clinical management strategies.A comprehensive literature search was conducted across bibliographic databases, primarily focusing on LR rates. Secondary outcomes included evaluation of positive surgical margins (PSM), nephrometry scores, pathological stage (T and grading), perioperative outcomes, time-to-LR, overall survival, and cancer-specific survival.Due to the heterogeneity, a narrative synthesis was performed. LR rates after PN varied in the literature; with PSM emerging as a significant risk factor. Other LR risk factors included pathological stage, nephrometry scores, and histological variants. However, evidence regarding optimal LR management in the absence of precise indications was lacking.LR represents a significant clinical challenge; requiring multidisciplinary assessment and shared decision-making with patients. Given well-established risk factors, clinicians must tailor management strategies to optimize patient outcomes.","PeriodicalId":73113,"journal":{"name":"Frontiers in urology","volume":"12 10","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lights and shadows on local recurrence after renal surgery: when, why and how to manage\",\"authors\":\"Luca Di Gianfrancesco, Alessandro Crestani, A. Amodeo, Paolo Corsi, Davide De Marchi, E. Miglioranza, G. Lista, Ferdinando Daniele Vitelli, Francesca Simonetti, G. Busetto, U. Falagario, Martina Maggi, Filippo Marino, Giannicola Genovese, R. Falabella, Angelo Porreca\",\"doi\":\"10.3389/fruro.2024.1419418\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This review aims to analyze the existing literature on local recurrence (LR) in patients undergoing partial nephrectomy (PN) for renal cell carcinoma, identifying relative risk factors, and exploring optimal clinical management strategies.A comprehensive literature search was conducted across bibliographic databases, primarily focusing on LR rates. Secondary outcomes included evaluation of positive surgical margins (PSM), nephrometry scores, pathological stage (T and grading), perioperative outcomes, time-to-LR, overall survival, and cancer-specific survival.Due to the heterogeneity, a narrative synthesis was performed. LR rates after PN varied in the literature; with PSM emerging as a significant risk factor. Other LR risk factors included pathological stage, nephrometry scores, and histological variants. However, evidence regarding optimal LR management in the absence of precise indications was lacking.LR represents a significant clinical challenge; requiring multidisciplinary assessment and shared decision-making with patients. Given well-established risk factors, clinicians must tailor management strategies to optimize patient outcomes.\",\"PeriodicalId\":73113,\"journal\":{\"name\":\"Frontiers in urology\",\"volume\":\"12 10\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in urology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3389/fruro.2024.1419418\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fruro.2024.1419418","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
本综述旨在分析有关肾细胞癌肾部分切除术(PN)患者局部复发(LR)的现有文献,确定相对风险因素,并探讨最佳临床管理策略。我们在文献数据库中进行了全面的文献检索,主要关注 LR 率。次要结果包括手术切缘阳性(PSM)评估、肾功能评分、病理分期(T和分级)、围手术期结果、LR发生时间、总生存率和癌症特异性生存率。文献中PN术后的LR率各不相同;PSM是一个重要的风险因素。其他 LR 风险因素包括病理分期、肾功能评分和组织学变异。LR 是一项重大的临床挑战,需要多学科评估并与患者共同决策。鉴于已确定的风险因素,临床医生必须量身定制管理策略,以优化患者的预后。
Lights and shadows on local recurrence after renal surgery: when, why and how to manage
This review aims to analyze the existing literature on local recurrence (LR) in patients undergoing partial nephrectomy (PN) for renal cell carcinoma, identifying relative risk factors, and exploring optimal clinical management strategies.A comprehensive literature search was conducted across bibliographic databases, primarily focusing on LR rates. Secondary outcomes included evaluation of positive surgical margins (PSM), nephrometry scores, pathological stage (T and grading), perioperative outcomes, time-to-LR, overall survival, and cancer-specific survival.Due to the heterogeneity, a narrative synthesis was performed. LR rates after PN varied in the literature; with PSM emerging as a significant risk factor. Other LR risk factors included pathological stage, nephrometry scores, and histological variants. However, evidence regarding optimal LR management in the absence of precise indications was lacking.LR represents a significant clinical challenge; requiring multidisciplinary assessment and shared decision-making with patients. Given well-established risk factors, clinicians must tailor management strategies to optimize patient outcomes.